中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2009年
8期
3-5
,共3页
陈秀娇%蔡庆发%张鹏飞%郑建盛
陳秀嬌%蔡慶髮%張鵬飛%鄭建盛
진수교%채경발%장붕비%정건성
乳腺癌%TK1%免疫组织化学
乳腺癌%TK1%免疫組織化學
유선암%TK1%면역조직화학
Breast carcinoma%TK1%Immunohisochemistry
目的 检测TK1在乳腺浸润性导管癌中的表达,探讨其在乳腺癌发生发展中的意义.方法 采用免疫组织化学SABC法检测50例乳腺浸润性导管癌及15例癌旁正常组织中的表达.结果 TK1在乳腺浸润性导管癌和癌旁正常组织中阳性表达率分别为70.0%(35/50)和6.7%(1/15),具有显著性差异,与病理分级密切相关,与年龄、淋巴结转移、临床分期、ER、PR无关.结论 TK1表达与肿瘤细胞增生和分级有关,有望成为肿瘤恶性度和预后判断的重要指标,但其确切机制以及与肿瘤进展间的关系需深入研究.
目的 檢測TK1在乳腺浸潤性導管癌中的錶達,探討其在乳腺癌髮生髮展中的意義.方法 採用免疫組織化學SABC法檢測50例乳腺浸潤性導管癌及15例癌徬正常組織中的錶達.結果 TK1在乳腺浸潤性導管癌和癌徬正常組織中暘性錶達率分彆為70.0%(35/50)和6.7%(1/15),具有顯著性差異,與病理分級密切相關,與年齡、淋巴結轉移、臨床分期、ER、PR無關.結論 TK1錶達與腫瘤細胞增生和分級有關,有望成為腫瘤噁性度和預後判斷的重要指標,但其確切機製以及與腫瘤進展間的關繫需深入研究.
목적 검측TK1재유선침윤성도관암중적표체,탐토기재유선암발생발전중적의의.방법 채용면역조직화학SABC법검측50례유선침윤성도관암급15례암방정상조직중적표체.결과 TK1재유선침윤성도관암화암방정상조직중양성표체솔분별위70.0%(35/50)화6.7%(1/15),구유현저성차이,여병리분급밀절상관,여년령、림파결전이、림상분기、ER、PR무관.결론 TK1표체여종류세포증생화분급유관,유망성위종류악성도화예후판단적중요지표,단기학절궤제이급여종류진전간적관계수심입연구.
Objective To test the expression of TK1 in the invasive ductal breast carcinoma and discuss its significance of carcinogenesis and progression in breast carcinoma.Methods Expression of TK1 Was tested by immunohisochemistry SABC method in 50 invasive ductal breast carcinoma and 15 normal tissue adjacent to carcinoma.Results Positive rates of TK1 in the invasive ductal breast carcinoma and normal tissue were 70.0% (35/50) and 6.7% (1/15),respectively,and there were some significant differences between them.The expression of TK1 was significantly associated with pathological grade,but Was no significantly relationship with age,lymph node metastasis,clinical stage,ER and PR in the breast carcinoma.Conclusion Expression of TK1 Was associated with proliferation and pathological grade,and niay serve as an important indictor for evaluating the malignancy and prognosis in breast cancer.But the precise mechanism and the relationship of the TKl expression with the neoplasm progress need further study.